Obstetrics

 
 APOSTEL VIII
 
 Dutch TRUFFLE
 
 2Close
 
 APRIL
 Highlow
 
 PC
 Quadruple P
 
 SIMPLE III
 
 Stop or Go?
 
 STRIDER
 
 SUGAR-DIP
 
 KEUZEHULP IMPLEMENTATIE
 
 INDEX
 MOTHER
 NethOSS
 Ppromexil-III
 ALLO
 AMPHIA
 APOSTEL-I
 APOSTEL-II
 APOSTEL-III
 APOSTEL-IV
 
 Apostel VI
 ASB
 CHIPS
 DIGITAT
 > ECV Implementation
 EuFis
 Fluxim
 GlucoMOMS
 HTA Longterm conseq.
 HTA Preference study
 HYPITAT
 HYPITAT-II
 HyRAS (Hypitat followup)
 Implementatie Tour
 IUPC
 PIMPP
 PPROMCerclage
 PPROMEXIL
 PreCare
 PROBAAT
 PROBAAT-II
 PROBAAT-S
 ProTWIN
 SimpleII
 STAN
 TeMpOH-1
 TeMpOH-3
 TOSTI
 TOTEM
 Triple P
 TRUFFLE
 WOMB study

 ABCD-study
 BIG CHANGE
 CAMPUR
 Cancer in pregnancy
 Doula study
 ECV tocolysis
 ECV Uterine relaxation
 EuroHeartSurvey
 FRUIT
 HP4ALL-PC
 HP4ALL-RS
 IMPACT
 INCAS
 IRIS
 Keizerlijk litteken
 MAKE
 OOPUS
 PRELHUDE
 PROMISES
 RAVEL
 SIMPLE
 STAN followup
 VET study
 VIS-project
 Wat bevalt beter
 ZAHARA II
 ZAHARA 3
 ZOBASII
 

 

ECV implementation



Go to the Implementation of ECV website


Objective
Breech presentation occurs in 3 4 % of al term pregnancies. External cephalic version (ECV)  is an intervention to prevent breech position at delivery and is therefore advised in guidelines for gynaecologists and midwifes. The implementation of external cephalic version is at maximum 70%, but probably less, and success rates of ECV are only 40%. The aim of the present study is to identify both impeding as well as facilitating factors and to develop and evaluate an implementation strategy based on proper counselling of pregnant women and their care providers.


Study design
During the first phase of the project we will identify both facilitating as well as impeding factors. Subsequently we will identify an implementation strategy focused on counselling of pregnant women with a child in breech position and counselling of their health care providers.
In the third phase of the project we will evaluate in a randomized clinical trial the effectiveness of the developed strategy. The study will be performed in 32 of the 100 Dutch hospitals.


Intervention
External cephalic version in breech position

 

Outcome measures
Primary: the number of patients that undergo an external cephalic version procedure.

Secondary: we will look at the number of babies in cephalic position at delivery.

Complications as a consequence of external cephalic version and the number of Caesarean sections as well as perinatal condition of mother and child. We will also assess the cost effectiveness of implementation strategies.


Time schedule
-
Assessment of barriers and facilitators: 12 months

- Development of the strategies: 6 months

- Randomised clinical trial: 12 months

- Evaluation and report: 6 months

 

Phase 1 Determinant analyses

Assessment quality indicators (month 1-4)

Focusgroup interview and individual interviews (month 1-6)

Questionnaires (month 4-12)

 

Phase 2 Implementation activities

Development implementation strategy  (month 8-12)

 

Phase 3 Evaluation

Pilot testing implementation strategy (month 13-14)

Carrying out implementation strategy 32 hospitals  (month 15-20)

Effect evaluation (month 18-32)

Process evaluation (month 28-32)

Cost analysis (month 20-36)

Analyses and report (month 28-36)

 

Determinant analysis

Focusgroup interview and individual interviews (month 1-6)

Questionnaires (month 4-10)

 

Implementation activities:

Development implementation strategy  (month 10-15)

 

Research activities:

Quality indicators  (month 4-10)

Feasibility study implementation strategy  (moth 10-14)

Preparation + implementation strategy (month 16-20)

Effect evaluation (month 20-31)

Process evaluation (month 20-31)

Cost analysis  (month 20-36)

Analyses and report (month 31-36)



Projectleaders
Prof. dr. B.W.J. Mol, gynaecologist, AMC Amsterdam

Dr. M. Kok, AMC Amsterdam